SEC Comment Letter 0000000000-23-000314 to Oculis Holding AG (OCS, OCSAW) (CIK 0001953530) (OCS)
Oculis Holding AG (OCS, OCSAW) (CIK 0001953530)
Date: Jan. 12, 2023 · CIK: 0001953530 · Accession: 0000000000-23-000314
AI Filing Summary & Sentiment
File numbers found in text: 333-268201
Show Raw Text
United States securities and exchange commission logo
January 12, 2023
Eduardo Bravo Fernandez de Araoz
Principal Executive Officer
Oculis Holding AG
Bahnhofstrasse 7
CH-6300
Zug, Switzerland
Re:Oculis Holding AG
Amendment No. 2 to Registration Statement on Form F-4
Filed January 6, 2023
File No. 333-268201
Dear Eduardo Bravo Fernandez de Araoz:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our December 20, 2022 letter.
Amendment No. 2 to Registration Statement on Form F-4
Material Swiss Tax Considerations, page 175
1.We note that the tax opinion filed as Exhibit 8.2 appears to be a short-form tax opinion.
Please revise this section to clearly identify that the "Material Swiss Tax Considerations"
disclosure is the opinion of counsel. Please also file a signed opinion.
Executive Officer and Director Compensation, page 268
2.Please revise your Executive Officer and Director Compensation section here and on page
292 to update compensation for the last full financial year.
FirstName LastNameEduardo Bravo Fernandez de Araoz
Comapany NameOculis Holding AG
January 12, 2023 Page 2
FirstName LastName
Eduardo Bravo Fernandez de Araoz
Oculis Holding AG
January 12, 2023
Page 2
You may contact Li Xiao at 202-551-4391 or Daniel Gordon at 202-551-3486 if you have
questions regarding comments on the financial statements and related matters. Please contact
Daniel Crawford at 202-551-7767 or Ada Sarmento at 202-551-3798 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Derek Dostal, Esq.